Medicare Enrolled

Dr. Ron Gallemore, MD

Ophthalmology · Torrance, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4201 TORRANCE BLVD, Torrance, CA 90503
3109449393
In practice since 2006 (20 years)
NPI: 1912968496 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gallemore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gallemore? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gallemore

Dr. Ron Gallemore is an ophthalmology specialist in Torrance, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gallemore performed 19,812 Medicare services across 5,600 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gallemore received a total of $23,306 from 33 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gallemore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in CA $23,306 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,812
Medicare services
Top 5% in CA for ophthalmology
5,600
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~991 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
5,520 $28 $72
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,693 $34 $101
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,913 $104 $413
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,546 $103 $392
Injection, ranibizumab, 0.1 mg 1,312 $182 $500
Aflibercept eye injection (Eylea) 1,174 $681 $1,250
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
642 $241 $528
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
517 $77 $191
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
501 $63 $85
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
480 $120 $307
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
416 $51 $146
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
414 $27 $98
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
334 $28 $180
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
308 $126 $250
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
168 $157 $207
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
159 $40 $210
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
150 $130 $362
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
136 $1 $2
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
121 $214 $547
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
87 $1,693 $4,352
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
62 $9 $36
Injection into eye membrane
A procedure involving the injection of a drug or substance into the membrane that covers the eyeball.
55 $44 $222
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
30 $53 $85
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
28 $21 $45
Laser repair of detached retina
A procedure that uses a laser to seal and reattach a detached retina to the back of the eye.
17 $266 $1,627
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
16 $989 $2,554
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
13 $25 $59
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,306
Total received (2018-2024)
Avg $3,329/year across 7 years
Top 9% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,273 (69.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,583 (24.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,449 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,513
2023
$1,290
2022
$766
2021
$3,370
2020
$347
2019
$13,104
2018
$2,916

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$465
Sandoz Inc.
$199
Regeneron Healthcare Solutions, Inc.
$196
Alcon Vision LLC
$159
Apellis Pharmaceuticals, Inc.
$120
Amgen Inc.
$119
ABBVIE INC.
$93
ANI Pharmaceuticals, Inc.
$46
Coherus Biosciences Inc.
$43
Mallinckrodt Hospital Products Inc.
$31
Alimera Sciences, Inc.
$22
Genentech USA, Inc.
$21
Top 3 companies account for 56.8% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$6,224
Bausch & Lomb, a division of Bausch Health US, LLC
$5,082
Aerie Pharmaceuticals, Inc.
$3,442
Allergan Inc.
$1,716
Eyevance Pharmaceuticals LLC
$1,493
Alcon Vision LLC
$769
Astellas Pharma US Inc
$736
ABBVIE INC.
$456
Alimera Sciences, Inc.
$389
Regeneron Healthcare Solutions, Inc.
$342
EyePoint Pharmaceuticals US, Inc.
$291
Genentech USA, Inc.
$277
Regeneron Pharmaceuticals, Inc.
$231
Alcon Laboratories Inc
$217
Mallinckrodt Hospital Products Inc.
$215
Apellis Pharmaceuticals, Inc.
$206
Sandoz Inc.
$199
Allergan, Inc.
$162
Novartis Pharmaceuticals Corporation
$151
Coherus Biosciences Inc.
$135
Amgen Inc.
$119
Thea Pharma Inc.
$65
Horizon Therapeutics plc
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$48
Mallinckrodt Enterprises LLC
$48
ANI Pharmaceuticals, Inc.
$46
Shire North American Group Inc
$39
Carl Zeiss Meditec AG
$39
Exeltis, USA Inc.
$36
Kala Pharmaceuticals, Inc.
$29
Akorn, Inc.
$18
Akorn Operating Company LLC
$18
Bausch & Lomb Americas Inc.
$15
Top 3 companies account for 63.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · Cimerli · Constellation · DEXYCU · DUREZOL · DURYSTA · EYLEA · EYLEA HD · Flarex · ILUVIEN · INVELTYS · Iluvien · Izervay · LOTEMAX SM · Lucentis · NGENUITY · None Specified · OZURDEX · PROLENSA · PURIFIED CORTROPHIN GEL · Rhopressa · Rocklatan · SIMBRINZA · SUSVIMO · Syfovre · TEPEZZA · TRAVATAN Z · VABYSMO · Vabysmo · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · YUTIQ · ZYLET · Zerviate · Zioptan · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for ophthalmology in CA.

Looking for an ophthalmology specialist in Torrance?
Compare ophthalmologists in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
719
Per 100K population
7.3
County median income
$87,760
Nearest hospital
PROVIDENCE LITTLE COMPANY OF MARY MED CTR TORRANCE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gallemore is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gallemore experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Gallemore performed 5,520 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gallemore receive payments from pharmaceutical companies?
Yes. Dr. Gallemore received a total of $23,306 from 33 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gallemore's costs compare to other ophthalmologists in Torrance?
Dr. Gallemore's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gallemore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →